Podcast: The promise of precision medicine

Posted By

Categories

Michael Joyce is a writer-producer with HealthNewsReview.org and tweets as @mlmjoyce

precision medicineIn the past half year the FDA has approved the first three gene therapies for use in the US.

This comes less than 18 years after the announcement that the human genome had been fully sequenced. It was a milestone wrapped in a promise; a promise that became known as “precision medicine.” But has that promise become reality?

In this podcast we turn to five leaders in their respective fields who’ve been intimately involved with this emerging technology. We ask them them to not only contrast what precision medicine is and may become, but also to help us clarify what holds promise and what’s just hype.

I mentioned the voices you heard in this podcast come from leaders in their respective fields. Taken together they represent a deeply informed and rich perspective on the state of precision medicine at the very beginning of 2018.

In order of their appearance in the podcast they are:

Eric Topol, MD • Scripps Research Institute

Mike Joyner, MD • Mayo Clinic

  • Anyone interested in the genetics and physiology of distance running might enjoy watching this YouTube video
  • Joyner is also a frequent contributor at HealthNewsReview.org. Here’s a sampling of his writing

 

Tim Caulfield, LL.B., LL.M. • University of Alberta

Richard Harris • National Public Radio

Tania Bubela, JD, PhD • Simon Fraser University

  • Bubela is one of the co-leaders at Paceomics, a consortium of Canadian researchers dedicated to bringing meaningful precision medicine to the Canadian public
  • A listing of some of her publications can be found HERE

Here’s where you can find more writing on precision medicine by the team at HealthNewsReview.org

Here is a complete listing of all our podcasts.

Comments

We Welcome Comments. But please note: We will delete comments left by anyone who doesn’t leave an actual first and last name and an actual email address.

We will delete comments that include personal attacks, unfounded allegations, unverified facts, product pitches, or profanity. We will also end any thread of repetitive comments. Comments should primarily discuss the quality (or lack thereof) in journalism or other media messages about health and medicine. This is not intended to be a forum for definitive discussions about medicine or science. Nor is it a forum to share your personal story about a disease or treatment -- your comment must relate to media messages about health care. If your comment doesn't adhere to these policies, we won't post it. Questions? Please see more on our comments policy.